{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T12:08:38Z","timestamp":1781525318135,"version":"3.54.1"},"reference-count":70,"publisher":"Elsevier BV","issue":"3","content-domain":{"domain":["bprclinrheum.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Rheumatology"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.berh.2013.07.010","type":"journal-article","created":{"date-parts":[[2013,11,15]],"date-time":"2013-11-15T07:16:32Z","timestamp":1384499792000},"page":"405-424","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"title":["Demyelinating disease in SLE: Is it multiple sclerosis or lupus?"],"prefix":"10.1016","volume":"27","author":[{"given":"C\u00e9sar","family":"Magro Checa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduard L.E.M.","family":"Bollen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"van Buchem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom W.J.","family":"Huizinga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerda M.","family":"Steup-Beekman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.berh.2013.07.010_bib1","first-page":"323","article-title":"Demyelinating diseases\u2013new pathological insights, new therapeutic targets","volume":"338","author":"Waxman","year":"1998","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.berh.2013.07.010_bib2","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1056\/NEJM200009283431307","article-title":"Multiple sclerosis","volume":"343","author":"Noseworthy","year":"2000","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.berh.2013.07.010_bib3","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1177\/1352458508096878","article-title":"Differential diagnosis of suspected multiple sclerosis: a consensus approach","volume":"14","author":"Miller","year":"2008","journal-title":"Multiple Sclerosis"},{"key":"10.1016\/j.berh.2013.07.010_bib4","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1474-4422(11)70274-5","article-title":"Clinically isolated syndromes","volume":"11","author":"Miller","year":"2012","journal-title":"Lancet Neurology"},{"key":"10.1016\/j.berh.2013.07.010_bib5","first-page":"290","article-title":"Demyelination in rheumatic diseases","volume":"77","author":"Theodoridou","year":"2006","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"key":"10.1016\/j.berh.2013.07.010_bib6","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/1529-0131(199904)42:4<599::AID-ANR2>3.0.CO;2-F","article-title":"The American College Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes","volume":"42","year":"1999","journal-title":"Arthritis & Rheumatism"},{"key":"10.1016\/j.berh.2013.07.010_bib7","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/art.22305","article-title":"Neuropsychiatric events at the time of diagnosis of systemic lupus erythematosus: an international inception cohort study","volume":"56","author":"Hanly","year":"2007","journal-title":"Arthritis & Rheumatism"},{"key":"10.1016\/j.berh.2013.07.010_bib8","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.semarthrit.2012.03.011","article-title":"Neuropsychiatric lupus: the prevalence and autoantibody associations depend on the definition: results from the 1000 faces of lupus cohort","volume":"42","author":"Borowoy","year":"2012","journal-title":"Seminars in Arthritis and Rheumatism"},{"key":"10.1016\/j.berh.2013.07.010_bib9","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/nrrheum.2010.62","article-title":"Pathogenesis, diagnosis and management of neuropsychiatric SLE manifestations","volume":"6","author":"Bertsias","year":"2010","journal-title":"Nature Reviews Rheumatology"},{"key":"10.1016\/j.berh.2013.07.010_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.semarthrit.2010.08.001","article-title":"Neuropsychiatric syndromes in systemic lupus erythematosus: a meta-analysis","volume":"41","author":"Unterman","year":"2011","journal-title":"Seminars in Arthritis and Rheumatism"},{"key":"10.1016\/j.berh.2013.07.010_bib11","doi-asserted-by":"crossref","first-page":"e55843","DOI":"10.1371\/journal.pone.0055843","article-title":"Incidence and prevalence of major central nervous system involvement in systemic lupus erythematosus: a 3 year prospective study of 370 patients","volume":"8","author":"Kampylafka","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.berh.2013.07.010_bib12","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/art.1780380415","article-title":"The prevalence and incidence of systemic lupus erythematosus in Birmingham, England. Relationship to ethnicity and country of birth","volume":"38","author":"Johnson","year":"1995","journal-title":"Arthritis & Rheumatism"},{"key":"10.1016\/j.berh.2013.07.010_bib13","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1093\/rheumatology\/keh532","article-title":"Multiple sclerosis, neuropsychiatric lupus and antiphospholipid syndrome: where do we stand?","volume":"44","author":"Ferreira","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.berh.2013.07.010_bib14","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1136\/ard.2010.148502","article-title":"Autoantibodies as biomarkers for the prediction of neuropsychiatric events in systemic lupus erythematosus","volume":"70","author":"Hanly","year":"2011","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1016\/j.berh.2013.07.010_bib15","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1093\/rheumatology\/41.6.619","article-title":"The central nervous system in systemic lupus erythematosus. Part 2. Pathogenetic mechanisms in clinical syndromes: a literature investigation","volume":"41","author":"Jennekans","year":"2002","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.berh.2013.07.010_bib16","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/ana.410440408","article-title":"A subgroup of multiple sclerosis patients with anticardiolipin antibodies and unusual clinical manifestations: do they represent a new nosological entity?","volume":"44","author":"Karussis","year":"1998","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.berh.2013.07.010_bib17","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1191\/096120399678847461","article-title":"Anti-phospholipid antibodies in patients with multiple sclerosis and MS-like illnesses: MS or APS?","volume":"8","author":"IJdo","year":"1999","journal-title":"Lupus"},{"key":"10.1016\/j.berh.2013.07.010_bib18","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/00005792-200001000-00006","article-title":"Can neurologic manifestations of Hughes (antiphospholipid) syndrome be distinguished from multiple sclerosis? Analysis of 27 patients and review of the literature","volume":"79","author":"Cuadrado","year":"2000","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.berh.2013.07.010_bib19","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/qjmed\/93.8.497","article-title":"Warfarin for multiple sclerosis?","volume":"93","author":"Ruiz-Irastorza","year":"2000","journal-title":"Quarterly Journal of Medicine"},{"key":"10.1016\/j.berh.2013.07.010_bib20","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jns.2011.09.032","article-title":"Type I interferon signature is high in lupus and neuromyelitis optica but low in multiple sclerosis","volume":"313","author":"Feng","year":"2012","journal-title":"Journal of the Neurological Sciences"},{"key":"10.1016\/j.berh.2013.07.010_bib21","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1177\/0961203307085112","article-title":"Proteomic analysis of autoantibodies in neuropsychiatric systemic lupus erythematosus patient with white matter hyperintensities on brain MRI","volume":"17","author":"Kimura","year":"2008","journal-title":"Lupus"},{"key":"10.1016\/j.berh.2013.07.010_bib22","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S1474-4422(12)70003-0","article-title":"Association between pathological and MRI findings in multiple sclerosis","volume":"11","author":"Filippi","year":"2012","journal-title":"Lancet Neurology"},{"key":"10.1016\/j.berh.2013.07.010_bib23","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1002\/art.27458","article-title":"The histopathologic associates of neurometabolite abnormalities in fatal neuropsychiatric systemic lupus erythematosus","volume":"62","author":"Brooks","year":"2010","journal-title":"Arthritis & Rheumatism"},{"key":"10.1016\/j.berh.2013.07.010_bib24","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.semarthrit.2009.08.005","article-title":"Magnetic resonance imaging and brain histopathology in neuropsychiatric systemic lupus erythematosus","volume":"40","author":"Sibbitt","year":"2010","journal-title":"Seminars in Arthritis and Rheumatism"},{"issue":"Suppl. 2","key":"10.1016\/j.berh.2013.07.010_bib25","doi-asserted-by":"crossref","first-page":"ii76","DOI":"10.1136\/annrheumdis-2012-202369","article-title":"Neuropsychiatric manifestations in patients with systemic lupus erythematosus: epidemiology and radiology pointing to an immune-mediated cause","volume":"72","author":"Steup-Beekman","year":"2013","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1016\/j.berh.2013.07.010_bib26","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S1474-4422(06)70572-5","article-title":"MRI and the diagnosis of multiple sclerosis: expanding the concept of \"no better explanation\"","volume":"5","author":"Charil","year":"2006","journal-title":"Lancet Neurology"},{"key":"10.1016\/j.berh.2013.07.010_bib27","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/art.30157","article-title":"Neuropsychiatric systemic lupus erythematosus: lessons learned from magnetic resonance imaging","volume":"63","author":"Luyendijk","year":"2011","journal-title":"Arthritis & Rheumatism"},{"key":"10.1016\/j.berh.2013.07.010_bib28","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1136\/ard.2010.130476","article-title":"EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs","volume":"69","author":"Bertsias","year":"2010","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1016\/j.berh.2013.07.010_bib29","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/S0002-9343(00)00603-3","article-title":"Predictors of clinical outcome and radiologic progression in patients with neuropsychiatric manifestations of systemic lupus erythematosus","volume":"109","author":"Karassa","year":"2000","journal-title":"American Journal of Medicine"},{"key":"10.1016\/j.berh.2013.07.010_bib30","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1093\/brain\/awf025","article-title":"Brain atrophy in clinically early relapsing-remitting multiple sclerosis","volume":"125","author":"Chard","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.berh.2013.07.010_bib31","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1148\/radiol.11101362","article-title":"MR imaging of multiple sclerosis","volume":"259","author":"Filippi","year":"2011","journal-title":"Radiology"},{"key":"10.1016\/j.berh.2013.07.010_bib32","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/jmri.22251","article-title":"Perfusion MRI in neuro-psychiatric systemic lupus erythematosus","volume":"32","author":"Emmer","year":"2010","journal-title":"Journal of Magnetic Resonance Imaging"},{"key":"10.1016\/j.berh.2013.07.010_bib33","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.3899\/jrheum.091276","article-title":"Elevated cerebral blood flow and volume in systemic lupus measured by dynamic susceptibility contrast magnetic resonance imaging","volume":"37","author":"Gasparovic","year":"2010","journal-title":"Journal of Rheumatology"},{"key":"10.1016\/j.berh.2013.07.010_bib34","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1002\/1529-0131(200011)43:11<2428::AID-ANR9>3.0.CO;2-H","article-title":"Detection of cerebral involvement in patients with active neuropsychiatric systemic lupus erythematosus using volumetric magnetization transfer imaging","volume":"43","author":"Bosma","year":"2000","journal-title":"Arthritis & Rheumatism"},{"key":"10.1016\/j.berh.2013.07.010_bib35","first-page":"1051","article-title":"Measure of magnetization transfer in multiple sclerosis demyelinating plaques, white matter ischemic lesions, and edema","volume":"17","author":"Mehta","year":"1996","journal-title":"American Journal of Neuroradiology"},{"key":"10.1016\/j.berh.2013.07.010_bib36","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/ana.20202","article-title":"Magnetization transfer ratio and myelin in postmortem multiple sclerosis brain","volume":"56","author":"Schmierer","year":"2004","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.berh.2013.07.010_bib37","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1148\/radiol.2223010413","article-title":"Systemic lupus erythematosus: diagnostic application of magnetization transfer ratio histograms in patients with neuropsychiatric symptoms-initial results","volume":"222","author":"Dehmeshki","year":"2002","journal-title":"Radiology"},{"key":"10.1016\/j.berh.2013.07.010_bib38","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.berh.2005.04.001","article-title":"Imaging in CNS lupus","volume":"19","author":"Peterson","year":"2005","journal-title":"Best Practice & Research Clinical Rheumatology"},{"key":"10.1016\/j.berh.2013.07.010_bib39","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1002\/art.27717","article-title":"Tract-based spatial statistics on diffusion tensor imaging in systemic lupus erythematosus reveals localized involvement of white matter tracts","volume":"62","author":"Emmer","year":"2010","journal-title":"Arthritis & Rheumatism"},{"key":"10.1016\/j.berh.2013.07.010_bib40","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/jon199884228","article-title":"High-resolution fluorodeoxyglucose positron emission tomography shows both global and regional cerebral hypometabolism in multiple sclerosis","volume":"8","author":"Bakshi","year":"1998","journal-title":"Journal of Neuroimaging"},{"key":"10.1016\/j.berh.2013.07.010_bib41","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1136\/ard.59.5.377","article-title":"Diagnosis and monitoring of central nervous system involvement in systemic lupus erythematosus: value of F-18 fluorodeoxyglucose PET","volume":"59","author":"Weiner","year":"2000","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1016\/j.berh.2013.07.010_bib42","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1468-1331.2010.03154.x","article-title":"Positron emission tomography imaging in multiple sclerosis-current status and future applications","volume":"18","author":"Kiferle","year":"2011","journal-title":"European Journal of Neurology"},{"key":"10.1016\/j.berh.2013.07.010_bib43","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1097\/RLU.0b013e3181e9fa7a","article-title":"Brain single photon emission computed tomography with Tc-99m MIBI or Tc-99m ECD in comparison to MRI in multiple sclerosis","volume":"35","author":"Assadi","year":"2010","journal-title":"Clinical Nuclear Medicine"},{"key":"10.1016\/j.berh.2013.07.010_bib44","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/art.23308","article-title":"Clinical validation of the watershed sign as a marker for neuropsychiatric systemic lupus erythematosus","volume":"59","author":"Driver","year":"2008","journal-title":"Arthritis & Rheumatism"},{"key":"10.1016\/j.berh.2013.07.010_bib45","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/BF02247855","article-title":"Evoked potentials in the assessment of neuropsychiatric manifestations in systemic lupus erythematosus","volume":"16","author":"Costallat","year":"1997","journal-title":"Clinical Rheumatology"},{"key":"10.1016\/j.berh.2013.07.010_bib46","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1136\/ard.2005.040352","article-title":"Evoked potential studies in the antiphospholipid syndrome: differential diagnosis from multiple sclerosis","volume":"65","author":"Paran","year":"2006","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1016\/j.berh.2013.07.010_bib47","doi-asserted-by":"crossref","first-page":"A395","DOI":"10.1016\/j.autrev.2009.12.007","article-title":"The epidemiology of transverse myelitis","volume":"9","author":"Bhat","year":"2010","journal-title":"Autoimmunity Reviews"},{"key":"10.1016\/j.berh.2013.07.010_bib48","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.2174\/138161208799316401","article-title":"Neuropsychiatric involvement in systemic lupus erythematosus: current therapeutic approach","volume":"14","author":"Sanna","year":"2008","journal-title":"Current Pharmaceutical Design"},{"key":"10.1016\/j.berh.2013.07.010_bib49","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1136\/ard.59.2.120","article-title":"Transverse myelopathy in systemic lupus erythematosus: an analysis of 14 cases and review of the literature","volume":"59","author":"Kovacs","year":"2000","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1016\/j.berh.2013.07.010_bib50","first-page":"280","article-title":"Transverse myelitis as the first manifestation of systemic lupus erythematosus or lupus-like disease: good functional outcome and relevance of antiphospholipid antibodies","volume":"31","author":"D'Cruz","year":"2004","journal-title":"Journal of Rheumatology"},{"key":"10.1016\/j.berh.2013.07.010_bib51","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.semarthrit.2008.09.002","article-title":"Transverse myelitis affecting more than 4 spinal segments associated with systemic lupus erythematosus: clinical, immunological, and radiological characteristics of 22 patients","volume":"39","author":"Espinosa","year":"2010","journal-title":"Seminars in Arthritis and Rheumatism"},{"key":"10.1016\/j.berh.2013.07.010_bib52","first-page":"467","article-title":"Acute transverse myelopathy in systemic lupus erythematosus: clinical presentation, treatment, and outcome","volume":"25","author":"Mok","year":"1998","journal-title":"Journal of Rheumatology"},{"key":"10.1016\/j.berh.2013.07.010_bib53","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1177\/0961203307088005","article-title":"Prognostic factors of lupus myelopathy","volume":"17","author":"Lu","year":"2008","journal-title":"Lupus"},{"key":"10.1016\/j.berh.2013.07.010_bib54","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/j.1468-1331.2010.03208.x","article-title":"Acute transverse myelitis and antiphospholipid antibodies in lupus. No evidence for anticoagulation","volume":"18","author":"Katsiari","year":"2011","journal-title":"European Journal of Neurology"},{"key":"10.1016\/j.berh.2013.07.010_bib55","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1002\/art.24937","article-title":"Distinct subtypes of myelitis in systemic lupus erythematosus","volume":"60","author":"Birnbaum","year":"2009","journal-title":"Arthritis & Rheumatism"},{"key":"10.1016\/j.berh.2013.07.010_bib56","first-page":"1911","article-title":"Lupus-related myelitis: serial MR findings","volume":"15","author":"Provenzale","year":"1994","journal-title":"American Journal of Neuroradiology"},{"key":"10.1016\/j.berh.2013.07.010_bib57","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/nrneurol.2011.176","article-title":"Longitudinal extensive transverse myelitis\u2013it's not all neuromyelitis optica","volume":"7","author":"Trebst","year":"2011","journal-title":"Nature Reviews Neurology"},{"key":"10.1016\/j.berh.2013.07.010_bib58","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1755-3768.2008.01193.x","article-title":"Systemic lupus erythematosus-associated optic neuritis: clinical experience and literature review","volume":"87","author":"Lin","year":"2009","journal-title":"Acta Ophthalmologica"},{"key":"10.1016\/j.berh.2013.07.010_bib59","first-page":"293","article-title":"Optic neuritis","volume":"vol. 1","author":"Smith","year":"2005"},{"key":"10.1016\/j.berh.2013.07.010_bib60","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/1352458511431077","article-title":"The emerging relationship between neuromyelitis optica and systemic rheumatologic autoimmune disease","volume":"18","author":"Wingerchuk","year":"2012","journal-title":"Multiple Sclerosis"},{"key":"10.1016\/j.berh.2013.07.010_bib61","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.autrev.2010.09.021","article-title":"Devic's syndrome and SLE: challenges in diagnosis and therapeutic possibilities based on two overlapping cases","volume":"10","author":"Polg\u00e1r","year":"2011","journal-title":"Autoimmunity Reviews"},{"key":"10.1016\/j.berh.2013.07.010_bib62","first-page":"CD002265","article-title":"Cyclophosphamide versus methylprednisolone for treating neuropsychiatric involvement in systemic lupus erythematosus","volume":"2","author":"Fernandes Mo\u00e7a Trevisani","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.berh.2013.07.010_bib63","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1046\/j.1526-0968.2003.00032.x","article-title":"The role of plasmapheresis in the treatment of severe central nervous system neuropsychiatric systemic lupus erythematosus","volume":"7","author":"Neuwelt","year":"2003","journal-title":"Therapeutic Apheresis and Dialysis"},{"key":"10.1016\/j.berh.2013.07.010_bib64","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.semarthrit.2011.06.004","article-title":"Rituximab therapy in refractory neuropsychiatric lupus: current clinical evidence","volume":"41","author":"Narv\u00e1ez","year":"2011","journal-title":"Seminars in Arthritis and Rheumatism"},{"key":"10.1016\/j.berh.2013.07.010_bib65","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1002\/art.23109","article-title":"A systematic review of secondary thromboprophylaxis in patients with antiphospholipid antibodies","volume":"57","author":"Ruiz-Irastorza","year":"2007","journal-title":"Arthritis & Rheumatism"},{"key":"10.1016\/j.berh.2013.07.010_bib66","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1212\/WNL.0b013e31823dc535","article-title":"Evidence-based guideline: clinical evaluation and treatment of transverse myelitis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology","volume":"77","author":"Scott","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.berh.2013.07.010_bib67","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s10067-011-1714-5","article-title":"Rituximab in the treatment of severe lupus myelopathy","volume":"30","author":"Ye","year":"2011","journal-title":"Clinical Rheumatology"},{"key":"10.1016\/j.berh.2013.07.010_bib68","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/MAJ.0b013e3181a8be1d","article-title":"Devic's syndrome as initial presentation of systemic lupus erythematosus","volume":"338","author":"Karim","year":"2009","journal-title":"American Journal of the Medical Sciences"},{"key":"10.1016\/j.berh.2013.07.010_bib69","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1002\/art.34468","article-title":"Progressive multifocal leukoencephalopathy associated with immunosuppressive therapy in rheumatic diseases: evolving role of biologic therapies","volume":"64","author":"Molloy","year":"2012","journal-title":"Arthritis & Rheumatism"},{"key":"10.1016\/j.berh.2013.07.010_bib70","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.autrev.2008.07.006","article-title":"Progressive multifocal leukoencephalopathy in patients with rheumatic diseases: are patients with systemic lupus erythematosus at particular risk?","volume":"8","author":"Molloy","year":"2008","journal-title":"Autoimmunity Reviews"}],"container-title":["Best Practice &amp; Research Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694213000624?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694213000624?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,19]],"date-time":"2024-05-19T13:04:09Z","timestamp":1716123849000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521694213000624"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":70,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S1521694213000624"],"URL":"https:\/\/doi.org\/10.1016\/j.berh.2013.07.010","relation":{},"ISSN":["1521-6942"],"issn-type":[{"value":"1521-6942","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Demyelinating disease in SLE: Is it multiple sclerosis or lupus?","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Rheumatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.berh.2013.07.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}